CD4 and non-small cell lung carcinoma: We enrolled 89 patients with NCT‐NSCLC in this study; the tumor‐infiltrating lymphocyte (TIL), CD4+TIL, and CD8+TIL levels in naïve and post‐chemotherapy tumor tissues were detected using immunohistochemistry staining and divided into high and low groups.